Faculty

Institution

Unit

Venue

Dong, Xiaowei

University of North Texas Health Science Center

Affiliations

College of Biomedical and Translational Sciences

Microbiology, Immunology and Genetics

Physiology and Anatomy

College of Health Professions

Studies Of Department Of Physician Assistant

University of North Texas Health Science Center

College of Public Health

Focused on Resources for her Health Education and Research (FOR HER)

Physical Medicine Institute

Texas Prevention Institute (TPI)

College of Public Health

Population And Community Health

School Of Public Health

Department Of Environmental And Occupational Health

Department Of Health Administration And Health Policy

Department Of Health Administration And Policy

Department Of Health Management And Policy

Department Of Population And Community Health

Texas College of Osteopathic Medicine

Department of Medical Education & Health Systems Science

Physical Medicine Institute

UNT System College of Pharmacy

Pharmacotherapy

NoneDong, Xiaowei is currently serving as a College Of Biomedical And Translational Sciences faculty at University of North Texas Health Science Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Dong, Xiaowei

University of North Texas Health Science Center

You can click a keyword to filter the displayed items

drug delivery controlled release biomedical engineering pharmacology nanoparticle research nano-drug delivery nanoparticles pharmaceutics pharmaceutical nanotechnology nanomedicine therapeutic nanomaterials drug delivery systems biological engineering situ self-assembly nanoparticles applied pharmacology biomaterials prostate cancer medicinal research pharmaceutical technology pharmaceutical sciences drug discovery clinical research in vitro toxicology tumor targeting medicine therapeutic targets cerebral blood flow pharmacotherapy clinical chemistry cellular therapy drug analysis biomedical analysis nanotoxicology neural tissue engineering protein nanoparticles pharmacological studies clinical pharmacology brain tumor research aging cell cell research cellular physiology continuous delivery neuromodulation (medicine) brain imaging immunological biomarkers clinical immunology extracellular microvesicles anti-cancer agents in vivo systems cerebral vascular regulation cerebral organoids bioequivalence pharmacokinetics surface nanotechnology infrared spectroscopy near-infrared spectroscopy drug allergy experimental toxicology clinical toxicology drug safety toxicology testing brain drug delivery current strategies extracellular vesicles t‐cell immunotolerance metformin bio-distribution relevant paradigm vivo evaluation curcumin nanoparticles current status poorly water-soluble drug oral solid granules docetaxel oral formulations nerve growth factor quetiapine oral suspension available tablets

Notable Scholarly Works

Notable Federal Grants

Collaborators

Influences of Formulations and Administration Routes on Docetaxel Tissue Distribution in Mice. Scientific Reports (2026)

drug metabolismadministration routespharmacological researchin vitro toxicologydocetaxel tissue distributionbiomedical engineeringpharmacologyapplied pharmacologypharmacological studiestissue (biology)clinical pharmacologyclinical researchpharmaceuticsdrug delivery

Binary Lipid System-Based Granules With Undissolved Drug Crystals Enhance Oral Bioavailability by Preventing Degradation and Improving Permeability. International Journal of Pharmaceutics (2025)

oral bioavailabilityundissolved drug crystalsbiomolecular engineeringbiological engineeringlipid preparationbiomedical engineeringdrug delivery systemslipidscontrolled releasepharmaceuticsdrug deliverybiopolymers

Enhancing Oral Absorption of an Ester Prodrug by Coating Drug Crystals With Binary Lipid Systems and Evaluating the Influence of Compositions. Pharmaceutics (2025)

pharmaceutical technologypharmaceutical sciencesbiological engineeringdrug crystalslipid preparationbinary lipid systemsdrug delivery systemspharmacologyester prodruglipidsexcipientscontrolled releasepharmaceuticsdrug deliverybiopolymers

Investigation of Hydrolysis of Olmesartan Medoxomil in Different Ph Buffers by Simultaneously Measuring Olmesartan Medoxomil and Olmesartan. PLoS ONE (2025)

different ph buffersolmesartan medoxomildrug analysisbiochemical engineeringpharmacologyanalytical toxicologyanalytical chemistrychemical engineering

Exploring Novel Type of Lipid-Bases Drug Delivery Systems That Contain One Lipid and One Water-Soluble Surfactant Only. International Journal of Pharmaceutics (2024)

pharmaceutical technologywater-soluble surfactantdelivery systemsnovel typebiological engineeringbiomoleculesdrug delivery systemspharmacologyapplied pharmacologylipidscontrolled releasedrug discoverypharmaceuticsdrug delivery

Maximum Tolerated Dose and Toxicity Evaluation of Orally Administered Docetaxel Granule in Mice. Toxicology Reports (2024)

Xiaowei DongJinmin Zhang

docetaxel granuledrug allergytoxicity evaluationexperimental toxicologyclinical toxicologypharmacologyapplied pharmacologydrug safetytoxicology testingoral medicinetoxinsdrug deliverytoxicology

The Development of Lipid-Based Sorafenib Granules to Enhance the Oral Absorption of Sorafenib. Pharmaceutics (2023)

lipid sciencelipid-based sorafenib granulesbioactive compoundsmedicinal researchlipid preparationbiomedical engineeringpharmacologylipidstherapeutic targetscontrolled releasepharmaceuticsdrug deliveryoral absorption

Current Status of in Vitro Models of the Blood-Brain Barrier. Current Drug Delivery (2022)

cerebral blood flowin vitro toxicologyin vivo systemscerebral vascular regulationneuroscienceblood vesselsbiomedical engineeringvascular biologycerebral organoidsneurophysiologycurrent status

Design and Evaluation of Two-Step Biorelevant Dissolution Methods for Docetaxel Oral Formulations. AAPS PharmSciTech (2022)

pharmaceutical technologypharmaceutical sciencesdocetaxel oral formulationsbiomedical engineeringpharmacologychromatographycontrolled releasepharmaceuticsdrug deliverybioequivalence

Development of in Situ Self-Assembly Nanoparticles to Encapsulate Lopinavir and Ritonavir for Long-Acting Subcutaneous Injection. Pharmaceutics (2021)

nanoparticlesencapsulate lopinavirpharmaceutical nanotechnologynano-drug deliverysitu self-assembly nanoparticlesbiomedical engineeringpharmacologytherapeutic nanomaterialsdrug delivery systemslong-acting subcutaneous injectionnanomedicinenanoparticle researchcontrolled releasepharmaceuticsdrug delivery

1
2
3
4
10 / page

Dong, Xiaowei

University of North Texas Health Science Center

Affiliations

College of Biomedical and Translational Sciences

Microbiology, Immunology and Genetics

Physiology and Anatomy

College of Health Professions

Studies Of Department Of Physician Assistant

University of North Texas Health Science Center

College of Public Health

Focused on Resources for her Health Education and Research (FOR HER)

Physical Medicine Institute

Texas Prevention Institute (TPI)

College of Public Health

Population And Community Health

School Of Public Health

Department Of Environmental And Occupational Health

Department Of Health Administration And Health Policy

Department Of Health Administration And Policy

Department Of Health Management And Policy

Department Of Population And Community Health

Texas College of Osteopathic Medicine

Department of Medical Education & Health Systems Science

Physical Medicine Institute

UNT System College of Pharmacy

Pharmacotherapy

NoneDong, Xiaowei is currently serving as a College Of Biomedical And Translational Sciences faculty at University of North Texas Health Science Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Dong, Xiaowei

University of North Texas Health Science Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Influences of Formulations and Administration Routes on Docetaxel Tissue Distribution in Mice. Scientific Reports (2026)

Binary Lipid System-Based Granules With Undissolved Drug Crystals Enhance Oral Bioavailability by Preventing Degradation and Improving Permeability. International Journal of Pharmaceutics (2025)

Enhancing Oral Absorption of an Ester Prodrug by Coating Drug Crystals With Binary Lipid Systems and Evaluating the Influence of Compositions. Pharmaceutics (2025)

Investigation of Hydrolysis of Olmesartan Medoxomil in Different Ph Buffers by Simultaneously Measuring Olmesartan Medoxomil and Olmesartan. PLoS ONE (2025)

different ph buffersolmesartan medoxomildrug analysisbiochemical engineeringpharmacologyanalytical toxicologyanalytical chemistrychemical engineering

Exploring Novel Type of Lipid-Bases Drug Delivery Systems That Contain One Lipid and One Water-Soluble Surfactant Only. International Journal of Pharmaceutics (2024)

Maximum Tolerated Dose and Toxicity Evaluation of Orally Administered Docetaxel Granule in Mice. Toxicology Reports (2024)

Xiaowei DongJinmin Zhang

docetaxel granuledrug allergytoxicity evaluationexperimental toxicologyclinical toxicologypharmacologyapplied pharmacologydrug safetytoxicology testingoral medicinetoxinsdrug deliverytoxicology

The Development of Lipid-Based Sorafenib Granules to Enhance the Oral Absorption of Sorafenib. Pharmaceutics (2023)

Current Status of in Vitro Models of the Blood-Brain Barrier. Current Drug Delivery (2022)

cerebral blood flowin vitro toxicologyin vivo systemscerebral vascular regulationneuroscienceblood vesselsbiomedical engineeringvascular biologycerebral organoidsneurophysiologycurrent status

Design and Evaluation of Two-Step Biorelevant Dissolution Methods for Docetaxel Oral Formulations. AAPS PharmSciTech (2022)

pharmaceutical technologypharmaceutical sciencesdocetaxel oral formulationsbiomedical engineeringpharmacologychromatographycontrolled releasepharmaceuticsdrug deliverybioequivalence

Development of in Situ Self-Assembly Nanoparticles to Encapsulate Lopinavir and Ritonavir for Long-Acting Subcutaneous Injection. Pharmaceutics (2021)

1
2
3
4
10 / page